2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 9.121.577 | 11.105.530 | 12.303.922 | 5.749.878 | 4.830.992 | 6.036.767 | 6.902.844 | 7.236.867 | 8.116.051 | 6.707.167 |
Total Income - EUR | 9.161.467 | 11.141.032 | 12.346.629 | 5.771.744 | 4.841.068 | 6.054.380 | 6.913.404 | 7.245.819 | 8.135.970 | 6.730.415 |
Total Expenses - EUR | 8.733.174 | 10.552.770 | 11.111.398 | 5.217.385 | 4.541.168 | 5.559.752 | 6.385.336 | 7.053.213 | 7.825.099 | 6.586.054 |
Gross Profit/Loss - EUR | 428.293 | 588.262 | 1.235.231 | 554.359 | 299.900 | 494.628 | 528.067 | 192.606 | 310.871 | 144.361 |
Net Profit/Loss - EUR | 354.759 | 485.876 | 1.033.399 | 468.038 | 249.637 | 419.687 | 454.884 | 164.393 | 266.286 | 122.118 |
Employees | 5 | 5 | 8 | 8 | 10 | 14 | 19 | 21 | 23 | 23 |
Check the financial reports for the company - For Pharma Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 26.889 | 224.328 | 150.946 | 112.353 | 123.914 | 81.077 | 46.377 | 98.491 | 69.692 | 47.143 |
Current Assets | 1.046.724 | 959.593 | 1.300.267 | 1.162.052 | 1.136.285 | 1.232.758 | 1.639.900 | 1.730.113 | 2.124.410 | 2.941.913 |
Inventories | 537.540 | 421.860 | 63.202 | 251.159 | 466.660 | 546.839 | 607.689 | 558.348 | 597.605 | 787.259 |
Receivables | 229.685 | 221.161 | 605.226 | 462.139 | 449.653 | 513.313 | 761.113 | 1.036.516 | 1.326.157 | 1.621.969 |
Cash | 279.498 | 316.572 | 631.840 | 448.754 | 219.972 | 172.607 | 271.098 | 135.248 | 200.648 | 532.685 |
Shareholders Funds | 491.769 | 885.333 | 1.033.666 | 474.925 | 249.895 | 664.743 | 455.132 | 164.635 | 266.529 | 185.675 |
Social Capital | 223 | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 |
Debts | 584.471 | 305.405 | 424.027 | 803.725 | 1.012.494 | 649.298 | 1.240.577 | 1.662.659 | 1.927.283 | 2.807.450 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.393 | 1.372 | 1.885 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4646 - 4646" | |||||||||
CAEN Financial Year |
4646
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - For Pharma Srl